← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2009Last known activity
Sep 30, 2024
Timeline
1960s
- Jun 1, 1966
Ache Laboratorios Farmaceuticos S.A.— Founded
Drugs by trial phase (48 distinct, 32 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (41 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Acute Lung Injury
- Asthma
- Back Pain
- Common Cold
- Coronavirus Infections
- Cough
- Diarrhea
- Dyslipidemias
- Epilepsy
- Headache
- Hypercholesterolemia
- Infections
- Inflammation
- Low Back Pain
- Lung Diseases
- Lung Diseases, Obstructive
- Migraine Disorders
- Mycoses
- Osteoarthritis
- Osteoarthritis, Knee
- Pain
- Pneumonia, Viral
- Pulmonary Disease, Chronic Obstructive
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Rhinitis
- Seizures
- Severe Acute Respiratory Syndrome
- Sleep Initiation and Maintenance Disorders
- Tinea
- Vaginal Discharge
- Vitiligo
Recent trials (32)
- NCT06577077Lead sponsorPhase 3Sep 30, 2024
- NCT06355856Lead sponsorPhase 4Apr 30, 2024
- NCT04327401CollaboratorPhase 3Apr 13, 2020
- NCT03508167Lead sponsorPhase 3Apr 1, 2019
- NCT03634514Lead sponsorPhase 4Aug 27, 2018
- NCT02582996Lead sponsorPhase 3Apr 1, 2018
- NCT02853578Lead sponsorPhase 3Mar 1, 2018
- NCT02904304Lead sponsorPhase 3Jan 1, 2018
- NCT02706015Lead sponsorPhase 3Oct 1, 2017
- NCT02582177Lead sponsorPhase 3Aug 1, 2017
- NCT02798367Lead sponsorPhase 2/Phase 3Aug 1, 2017
- NCT02985671Lead sponsorPhase 3Jun 1, 2017
- NCT02409381Lead sponsorPhase 4Jun 1, 2015
- NCT01702675Lead sponsorPhase 1May 1, 2015
- NCT02581397Lead sponsorPhase 3May 1, 2015
Details
- Founded
- Guarulhos, BR Jun 1, 1966
- Last known activity
- Sep 30, 2024